Risperidone in the treatment of psychotic depression

Clinical Neuropharmacology

Volumn 23, Issue 6, 2000, Pages 335-337

  Miodownik, Chanoch ^a   Lerner, Vladimir ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MENTAL HEALTH CENTER   (Israel)

Author keywords

2 adrenergic affinities; 5HT2 receptors; Monotherapy; Psychotic depression; Risperidone

Indexed keywords

HALOPERIDOL; RISPERIDONE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; RATING SCALE; TREATMENT INDICATION;

ADULT; ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER; FEMALE; HUMANS; PSYCHOTIC DISORDERS; RISPERIDONE; SUICIDE, ATTEMPTED;

EID: 0034518578     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200011000-00007     Document Type: Article

References (28)

1. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression
2. The pharmacologic treatment of delusional depression
3. Fluvoxamine alone in the treatment of delusional depression
4. Efficacy of the combination of fluoveline and perphenazine in the treatment of psychotic depression
5. Delusional depression: Phenomenology and response to treatment
6. Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression
7. The treatment of psychotic depression
8. Antipsychotic agents and bipolar disorder
9. Clozupine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenta
10. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome - A functional approach
11. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder
12. Clozapine in severe mood disorders
13. Treatment of psychotic depression
14. Long-term treatment of mood disorders in schizophrenia
15. Risperidone plus a monoamine oxidase inhibitor for agitated depression crisis
16. Risperidone versus hatoperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome
17. Adding risperidone to selective serotonin reuptake inhibitor improves chronic depression
18. Risperidone monotherapy for psychotic depression unresponsive to other treatments
19. Risperidone in the treatment of mania
20. Manic symptoms associated with initiation of risperidone
21. Mania induced by risperidone: Dose related?
22. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders
23. Efficacy and safety of risperidone in psychotic patients: An open study
24. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses
25. Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression
26. Reduction of serotonin-2 receptors in rat cerebral cortex after subchronic administration of imipramine, chlorpromazine and the combination thereof
27. Induction of mania by risperidone resistant to mood stabilizers
28. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties